Bupivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Kindos Pharmaceuticals Co. Ltd. with status Current. The shortage was first posted on 02/20/2018. Reported reason: Discontinuation of the manufacture of the drug
Shortage Details
- Status
- Current
- Company
- Kindos Pharmaceuticals Co. Ltd.
- Package NDC
- 71288-726-52
- Dosage Form
- Injection
- Presentation
- Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)
- Initial Posting
- 02/20/2018
- Revised Date
Reason
Discontinuation of the manufacture of the drug